T Martin

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study
    Amy Riedel
    Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, USA
    BMC Infect Dis 7:70. 2007
  2. ncbi Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation
    T Martin
    Division of Hematology Oncology, University of California San Francisco, San Francisco, California, USA
    Transpl Infect Dis 12:45-50. 2010
  3. doi Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma
    L Damon
    Division of Hematology Oncology, University of California, San Francisco, CA 94143 0324, USA
    Bone Marrow Transplant 42:649-57. 2008

Collaborators

  • L Damon
  • Amy Riedel
  • C Linker
  • K Gaensler
  • L E Damon
  • L Kaplan
  • J Rubenstein
  • John Inciardi
  • Lan Choe
  • B Joseph Guglielmo
  • Courtney Yuen

Detail Information

Publications3

  1. pmc Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study
    Amy Riedel
    Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, USA
    BMC Infect Dis 7:70. 2007
    ..The aim of our study was to compare outcomes associated with the two regimens, including breakthrough fungal infection, adverse drug events, and costs...
  2. ncbi Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation
    T Martin
    Division of Hematology Oncology, University of California San Francisco, San Francisco, California, USA
    Transpl Infect Dis 12:45-50. 2010
    ..No Candida infections were seen in either period. These data suggest that fungal prophylaxis with VOR following allogeneic transplantation is safe and effective...
  3. doi Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma
    L Damon
    Division of Hematology Oncology, University of California, San Francisco, CA 94143 0324, USA
    Bone Marrow Transplant 42:649-57. 2008
    ..The equalization of EFS and superiority of OS in patients intensely mobilized to those nonintensely mobilized suggests that a treatment strategy using intensive chemotherapy for mobilization may be improving NHL outcomes after ASCT...